Details of the Drug Formulaction

General Information of Drug Formulation (ID: F24298)

• Formulation Name: Talazoparib 0.25 mg capsule
• Company: Pfizer Laboratories Div Pfizer

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Talazoparib	(DM1KS78)	Breast cancer	2C60-2C65	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Ammonium hydroxide	(E00687)	Not Available	Alkalizing agent
Colcothar yellow	(E00436)	518696	Colorant
Ferric oxide black	(E00522)	16211978	Colorant
Haematite red	(E00236)	14833	Colorant
Hypromellose	(E00634)	Not Available	Coating agent
Potassium hydroxide	(E00233)	14797	Alkalizing agent
Propylene glycol	(E00040)	1030	Antimicrobial preservative; Humectant; Plasticizing agent; Solvent
Shellac	(E00695)	Not Available	Coating agent; Film/membrane-forming agent; Microencapsulating agent; Modified-release agent
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent